MARKET

INSM

INSM

Insmed Inc
NASDAQ
65.08
-0.55
-0.84%
After Hours: 65.00 -0.08 -0.12% 19:58 05/09 EDT
OPEN
65.63
PREV CLOSE
65.63
HIGH
66.91
LOW
64.95
VOLUME
2.39M
TURNOVER
--
52 WEEK HIGH
84.91
52 WEEK LOW
21.92
MARKET CAP
11.83B
P/E (TTM)
-10.9450
1D
5D
1M
3M
1Y
5Y
1D
Insmed Is Maintained at Buy by UBS
Dow Jones · 1d ago
Insmed Price Target Cut to $109.00/Share From $110.00 by UBS
Dow Jones · 1d ago
UBS Maintains Buy on Insmed, Lowers Price Target to $109
Benzinga · 1d ago
Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates
NASDAQ · 1d ago
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Benzinga · 1d ago
INSMED INC <INSM.O>: UBS CUTS TARGET PRICE TO $109 FROM $110
Reuters · 1d ago
Insmed price target lowered to $109 from $110 at UBS
TipRanks · 1d ago
Insmed (INSM) Gets a Buy from Truist Financial
TipRanks · 1d ago
More
About INSM
More
Insmed Incorporated is a global biopharmaceutical company. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as drug discovery. Its advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company’s pre-clinical research programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Its first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib, TPIP, and INS1201 as well as pre-clinical research programs.
Recently
Symbol
Price
%Change

Webull offers Insmed Inc stock information, including NASDAQ: INSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INSM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INSM stock methods without spending real money on the virtual paper trading platform.